Interested in learning about how pharmaceutical drugs are developed? WIB-Southern California YWIB is excited to host an event with La Jolla Pharmaceutical Company for students interested in learning how scientists discover and develop drug therapies for patients suffering from life-threatening diseases. Attendees will tour the lab facilities and participate in interactive sessions. La Jolla Pharmaceutical scientists will lead a discuss on how they develop drugs for commercialization to benefit patients. Students will have the opportunity to meet professional women from La Jolla Pharmaceutical, who will share their passion and personal experience working in the biotech industry.
Please read the YWIB permission forms located here.
Jennifer Carver, Chief Operating Officer, La Jolla Pharmaceutical Company. With over 20 years of experience in the healthcare industry, Jennifer Carver is passionate about small biotech companies and helping them grow. Her skills lie in the ability to build and integrate operational functions, mentor project teams, and as part of the executive team to collaborate on building the company’s vision and strategy. She has experience with early development through commercialization across multiple therapeutic areas including oncology, inflammatory disease, shock, iron overload and anti-infectives. At La Jolla Pharmaceutical Company, Jennifer is responsible for operational and financial oversight of business development, clinical operations, regulatory affairs, pharmaceutical operations, legal operations, project management, information technology and quality.
Robin Marsden, Associate Director, Bioanalytical at La Jolla Pharmaceutical Company Over the last 23 years, Robin Marsden has developed and validated assays for the detection of small molecules, peptides, PEGylated biotherapeutics, and antibody drug conjugates in circulation, with specialization in the assessment of immunogenicity. Robin started her career investigating cancer immunotherapeutics for Viagene, then moved into immunological assessment of peptide therapeutics for Neurocrine Biosciences, then immunotherapeutics for Dynavax and the Department of Medicine at UCSD. Her efforts have since focused on GLP-regulated bioanalysis and immunogenicity assessments at Amylin Pharmaceuticals and Ambrx, Inc. Robin Marsden is currently the Associate Director of Bioanalytical at La Jolla Pharmaceutical, which includes bioanalysis performed across multiple disciplines including plate-based assays, cell-based assays, and small molecule analysis.
Kat Stemmer, Sr. Manager, Facilities at La Jolla Pharmaceutical Company Kat Stemmer started her career in Biotech in 2007 in customer service/order entry. Over the years she expanded her skills set into many different areas, utilizing her supply chain education. Kat has handled everything from order entry, international shipping, inventory management, production planning, purchasing, and facilities management. In 2015 she joined La Jolla Pharmaceutical, starting out as the Lab Administrator, and she is now the Sr. Manager of Facilities. In her current role, she is responsible for the daily operation of a 68,000 square foot facility, of which 24,000 square feet is dedicated laboratory space that has several specialized utility systems. Kat was part of the committee that created the building design, worked with all the functional groups, project managers, furniture providers, and general contractors to build the current state of the art LJPC facility.
YWIB Participant Age Range
13-18 years old
Walk-ins and guests are not accepted – be sure to register early!
5:30 p.m. - 5:45 p.m. Welcome, Intro & Overview on Drug Development at LJPC
5:45 p.m. - 6:00 p.m. Lab Tour
6:00 p.m. - 6:35 p.m. Bioanalytical Demo
6:35 p.m. - 6:45 p.m. Break/Refreshments
6:45 p.m. - 7:00 p.m. Patient Perspective
7:00 p.m. - 7:30 p.m. Final Message, Q&A
April 16, 2018
Free on-site parking